June 9th, 2014
Selections from Richard Lehman’s Literature Review: June 9th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include the CORONARY trial, the association of azithromycin with mortality and CV events among older patients hospitalized with pneumonia, and more.
March 24th, 2014
Selections from Richard Lehman’s Literature Review: March 24th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include non-leg venous thrombosis in critically ill adults, a comparison of factor Xa inhibitors and warfarin for preventing stroke and thromboembolism in atrial fibrillation, and more.
March 10th, 2014
Selections from Richard Lehman’s Literature Review: March 10th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include cognitive function and brain structure in type 2 diabetics after intensive lowering of BP and lipid levels, the association of β-blocker therapy with risks of adverse CV events and deaths in those with ischemic heart disease undergoing noncardiac surgery, and more.
February 17th, 2014
Selections from Richard Lehman’s Literature Review: February 17th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include hospital variation in noninvasive cardiac imaging, percutaneous renal denervation in patients with treatment-resistant hypertension, and more.
February 3rd, 2014
Intensive BP, Lipid Lowering Does Not Protect Against Cognitive Decline in Diabetics
Nicholas Downing, MD
Intensive treatment of blood pressure or cholesterol does not slow the rate of cognitive decline in adults with type 2 diabetes, according to a substudy of the ACCORD trial published in JAMA Internal Medicine. Some 3000 older adults with poorly controlled diabetes, high cardiovascular risk, and no evidence of cognitive impairment were assigned to one of […]
January 6th, 2014
Mediterranean Diet Protects Against Diabetes, Regardless of Weight Loss
Larry Husten, PHD
Even if it doesn’t lead to weight loss, a Mediterranean diet could help prevent the onset of type 2 diabetes, according to a subanalysis of last year’s influential PREDIMED study. In the main trial, reported in the New England Journal of Medicine, nearly 7500 people at high risk for cardiovascular disease were randomized to a low-fat […]
October 28th, 2013
Selections from Richard Lehman’s Literature Review: October 28th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include thrombus aspiration during STEMI, the effect of statins on mortality in patients with ventilator-associated pneumonia, and more.
October 22nd, 2013
Are Sulfonylureas Dangerous?
Kasia Lipska, MD, MHS
Endocrinologist Kasia Lipska shares her thoughts about a presentation by Craig Currie at this year’s annual meeting of the European Association for the Study of Diabetes.
October 7th, 2013
Selections from Richard Lehman’s Literature Review: October 7th
Richard Lehman, BM, BCh, MRCGP
This week’s topics include several papers on the CV safety of diabetes drugs, a follow-up report from the WHI on hormone therapy, clopidogrel and smoking, and more.
September 7th, 2013
Visit-to-Visit Variability in Systolic BP Among Patients with Type 2 Diabetes
John Chalmers, MD phD and John Ryan, MD
John Chalmers and his coauthors discuss their analysis of data from the ADVANCE trial.
NEJM Journal Watch — Recent Cardiology Articles- GLP-1 Agonists and SGLT-2 Inhibitors Together Have Greater Cardiorenal Benefits
- More Data Support Semaglutide for Obesity-Related HFpEF, Regardless of Diabetes Diagnosis
- A Novel Agent Fails to Improve Outcomes in Diabetic Cardiomyopathy
- Persistent Symptoms After Valve Replacement for Severe Aortic Stenosis
- Is Diltiazem Safe in Patients with AF Taking Apixaban or Rivaroxaban?